Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -260.5% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 12.8 | n/a |
Pr/Book | 1.3 |
Latest | F'cast | |
---|---|---|
Revenue | 35.1% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 1.52 | 5.71 | 6.65p | 8.7 | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 2.21 | 6.18 | 7.15p | 6.4 | 0.8 | +8% | n/a | 0.0% |
31-Dec-22 | 0.46 | 2.44 | 2.93p | 4.5 | n/a | -59% | n/a | 0.0% |
31-Dec-23 | 0.64 | (2.04) | (2.24)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-24 | 0.87 | (1.87) | (1.84)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Director/PDMR Shareholding | 02-Oct-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 24-Sep-2025 | 12:28 | RNS |
Half-year Report | 16-Sep-2025 | 07:00 | RNS |
£5.7m float for weight-fighting OptiBiotix after... | 04-Aug-2014 | Express & Star |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
01-Oct-25 | Buy | David Blain | 1,175.00p | 84,053 | £987,622.75 |
23-Sep-25 | Buy | Stephen O'Hara | 10.50p | 95,238 | £9,999.99 |
22-Sep-25 | Buy | Stephen O'Hara | 9.78p | 50,000 | £4,890.00 |
Currency | UK Pounds |
Share Price | 10.75p |
Change Today | -0.25p |
% Change | -2.27 % |
52 Week High | 22.60 |
52 Week Low | 9.50 |
Volume | 228,852 |
Shares Issued | 103.30m |
Market Cap | £11.10m |
Beta | 0.05 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:22 | 95 @ 10.55p |
16:20 | 33 @ 10.50p |
16:09 | 68,580 @ 10.50p |
16:07 | 53,750 @ 10.65p |
15:28 | 800 @ 11.00p |
CEO | Stephen O'Hara |
Finance Director | David Blain |
You are here: research